1 Oct 2025Open access
Probiotics mitigates ovarian angiogenic disturbance in letrozole-induced PCOSPublisher siteBMC Complementary Medicine and Therapies, Ovarian function and disorders
UniversitiesChukwubueze L. Atuma
Active, last published 2026
Chukwubueze L.
Atuma
Scholar“Research profile drawn from open scholarly records.”
Afe Babalola University
Claim Your Profile2
H-index
18
Citations
Chukwubueze has not officially claimed their profile. If you are Chukwubueze, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Chukwubueze L. Atuma will appear here once their profile is updated.
02 · Reach
Publication output and reach
Chukwubueze's work has been cited 18 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchAfe Babalola UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works30 Jun 2025Open access
Acetate alleviates glucose dysregulation and atherogenic dyslipidaemia in experimentally induced PCOSPublisher siteBabcock University Medical Journal, Cardiovascular Disease and Adiposity
13 May 2025Open access2cites
Renometabolic disorder in experimental rat model of polycystic ovarian syndrome is reversed by acetate-mediated inhibition of pyruvate dehydrogenase kinase 4Publisher siteBMC Nephrology, Biochemical Acid Research Studies
12 Mar 20256cites
Probiotics ameliorates hypothalamic amenorrhea in a rat model of PCOSPublisher siteMetabolic Brain Disease, Hypothalamic control of reproductive hormones
19 Jun 2024
Hepatic dysmetabolism in polycystic ovarian syndrome: impact of paraoxonase-1 modulation by butyratePublisher siteComparative Clinical Pathology, Paraoxonase enzyme and polymorphisms
15 Jun 202310cites
Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndromePublisher siteToxicology and Applied Pharmacology, Ovarian function and disorders
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Chukwubueze?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you